University of California, Irvine, 1991, PhD (Microbiology & Molecular Genetics)
Boston University School of Medicine, 1996, MD
Dr. Pagel leads leukemia studies of Radioimmunotherapy at the Center as the principal investigator of several human clinical trials. He is working to increase the usefulness of antibody therapy by "pretargeting" radiation directly to the cells. He is also researching nonradioactive chemical partners to antibodies.